Literature DB >> 16259046

Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers.

Mario Thevis1, Alexander A Makarov, Stevan Horning, Wilhelm Schänzer.   

Abstract

Mass spectrometric identification and characterization of growth-promoting anabolic-androgenic steroids in biological matrices has been a major task for doping control as well as food safety laboratories. The fragmentation behavior of stanozolol, its metabolites 17-epistanozolol, 3'-OH-stanozolol, 4alpha-OH-stanozolol, 4beta-OH-stanozolol, 17-epi-16alpha-OH-stanozolol, 16alpha-OH-stanozolol, 16beta-OH-stanozolol, as well as the synthetic analogues 4-dehydrostanozolol, 17-ketostanozolol, and N-methyl-3'-OH-stanozolol, was investigated after positive electrospray ionization and subsequent collision-induced dissociation utilizing a quadrupole-linear ion trap and a novel linear ion trap-orbitrap hybrid mass spectrometer. Stable isotope labeling, H/D-exchange experiments, MS3 analyses and high-resolution/high mass accuracy measurements of fragment ions were employed to allow proposals for charge-driven as well as charge-remote fragmentation pathways generating characteristic product ions of stanozolol at m/z 81, 91, 95, 105, 119, 135 and 297 and 4-hydroxylated stanozolol at m/z 145. Fragment ions were generated by dissociation of the steroidal A- and B-ring retaining the introduced charge within the pyrazole function of stanozolol and by elimination of A- and B-ring fractions including the pyrazole residue. In addition, a charge-remote fragmentation causing the neutral loss of methanol was observed, which was suggested to be composed by the methyl residue at C-18 and the hydroxyl function located at C-17. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259046     DOI: 10.1002/rcm.2204

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements.

Authors:  Scott M Peterman; Nicholas Duczak; Amit S Kalgutkar; Mary E Lame; John R Soglia
Journal:  J Am Soc Mass Spectrom       Date:  2006-01-25       Impact factor: 3.109

2.  Implementation of electron-transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer.

Authors:  Graeme C McAlister; Doug Phanstiel; David M Good; W Travis Berggren; Joshua J Coon
Journal:  Anal Chem       Date:  2007-04-19       Impact factor: 6.986

3.  Novel fragmentation pathways of anionic adducts of steroids formed by electrospray anion attachment involving regioselective attachment, regiospecific decompositions, charge-induced pathways, and ion-dipole complex intermediates.

Authors:  Nalaka S Rannulu; Richard B Cole
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-26       Impact factor: 3.109

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

5.  Analysis of non-conjugated steroids in water using paper spray mass spectrometry.

Authors:  Fred P M Jjunju; Deidre E Damon; David Romero-Perez; Iain S Young; Ryan J Ward; Alan Marshall; Simon Maher; Abraham K Badu-Tawiah
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

6.  Identification of lignin oligomers in Kraft lignin using ultra-high-performance liquid chromatography/high-resolution multiple-stage tandem mass spectrometry (UHPLC/HRMSn).

Authors:  Jens Prothmann; Peter Spégel; Margareta Sandahl; Charlotta Turner
Journal:  Anal Bioanal Chem       Date:  2018-10-10       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.